Lupin to add GLP 1 analog to its diabetes portfolio in India Ruby Khatun Khatun13 Sep 2017 9:37 AM GMTMumbai: Lupin plans to introduce a new class of diabetes drugs in India through in-licensing agreements in order to enhance its diabetes drugs...